Responses
Regular and young investigator award abstracts
Clinical trials completed
273 Phase i study of LioCyx-M, autologous hepatitis B virus (HBV)-specific T cell receptor (TCR) T-cells, in recurrent HBV-related hepatocellular carcinoma (HCC) post-liver transplantation
Compose a Response to This Article
Other responses
No responses have been published for this article.